The CEO of Novo Nordisk is defending the high cost of Ozempic and Wegovy in America, saying the blockbuster drugs are ultimately saving taxpayers money on obesity-related costs.
Read More
Enter your details below to save your shopping cart for later. And, who knows, maybe we will even send you a sweet discount code :)
Allow notifications to get real-time updates about your shopping cart and who knows, you may even receive a sweet discount code 😊